|
JPS6037953A
(ja)
*
|
1983-08-11 |
1985-02-27 |
Herusu Eido:Kk |
カルシウムを主成分とする栄養補助食品
|
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
GB9402203D0
(en)
*
|
1994-02-04 |
1994-03-30 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US5531989A
(en)
|
1994-10-28 |
1996-07-02 |
Metagenics, Inc. |
Immunoglobulin and fiber-containing composition for human gastrointestinal health
|
|
US6241983B1
(en)
|
1994-10-28 |
2001-06-05 |
Metagenics, Inc. |
Bacteria-and fiber-containing composition for human gastrointestinal health
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
DE59706697D1
(de)
*
|
1997-12-19 |
2002-04-25 |
Merck Patent Gmbh |
Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
|
|
JP2000302694A
(ja)
|
1999-04-16 |
2000-10-31 |
Fuyuki Mitsuyama |
医食兼用物質
|
|
US6696057B1
(en)
|
1999-09-22 |
2004-02-24 |
Lacpro Industries, Inc. |
Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
|
|
US20020044926A1
(en)
|
1999-12-10 |
2002-04-18 |
Gregor Reid |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
|
US20030118547A1
(en)
*
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
PT1251832E
(pt)
|
2000-02-04 |
2007-01-31 |
Depomed Inc |
Forma de dosagem constituída por invólucro-e-núcleo que conduz a uma libertação do fármaco de ordem zero
|
|
EP1151673A3
(en)
|
2000-05-03 |
2002-01-02 |
Societe Des Produits Nestle S.A. |
Confectionery product having a filling
|
|
JP5186077B2
(ja)
|
2000-12-18 |
2013-04-17 |
プロバイオヘルス・エルエルシー |
ラクトバシラス−カゼイｋｅ０１株から得られたプロバイオティック化合物
|
|
AUPR272901A0
(en)
|
2001-01-25 |
2001-02-22 |
Gainful Plan Limited |
Method of preparing biological materials and preparations produced using same
|
|
EP1228769A1
(de)
|
2001-02-02 |
2002-08-07 |
Jörg-Peter Prof. Schür |
Symbiontisches Regenerativum
|
|
AU2002245979A1
(en)
|
2001-04-05 |
2002-10-21 |
Universite Laval |
Process for making protein delivery matrix and uses thereof
|
|
US6627220B2
(en)
|
2001-07-13 |
2003-09-30 |
Scolr, Inc. |
Tablets containing heat sensitive materials and method for forming thereof
|
|
US8048924B2
(en)
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
|
US20070098784A1
(en)
*
|
2001-09-28 |
2007-05-03 |
Nutraceutix, Inc. |
Delivery system for biological component
|
|
CA2778208C
(en)
|
2001-09-28 |
2015-11-10 |
Tntgamble Inc. |
Delivery system for biological component
|
|
US7101565B2
(en)
|
2002-02-05 |
2006-09-05 |
Corpak Medsystems, Inc. |
Probiotic/prebiotic composition and delivery method
|
|
EP1344458A1
(en)
|
2002-03-12 |
2003-09-17 |
Société des Produits Nestlé S.A. |
Probiotic delivery system
|
|
US20030175295A1
(en)
|
2002-03-15 |
2003-09-18 |
Richard Ticktin |
Composition and method for reducing odors from metabolic processes
|
|
US7670612B2
(en)
|
2002-04-10 |
2010-03-02 |
Innercap Technologies, Inc. |
Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
TW200404544A
(en)
*
|
2002-06-17 |
2004-04-01 |
Kowa Co |
Controlled release pharmaceutical composition
|
|
US20050266069A1
(en)
|
2002-09-06 |
2005-12-01 |
Simmons Donald L |
Stable probiotic microsphere compositions and their methods of preparation
|
|
US8168170B2
(en)
|
2002-10-03 |
2012-05-01 |
The Procter And Gamble Company |
Compositions having an inner core and at least three surrounding layers
|
|
US7105336B2
(en)
|
2002-10-07 |
2006-09-12 |
Biogaia Ab |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
|
|
CA2504610C
(en)
*
|
2002-11-12 |
2012-02-21 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
|
US20060188563A1
(en)
|
2003-03-27 |
2006-08-24 |
Hisamitsu Pharmaceutical Co., Inc. |
Medicinal oral preparations for colon delivery, medicinal oral preparations for treating colon cancer and medicinal oral preparations for treating colitis
|
|
US7025998B2
(en)
|
2003-05-30 |
2006-04-11 |
Rotta Research Laboratorium S.P.A. |
Phytoestrogens and probiotic for women's health
|
|
EP1661983B1
(en)
|
2003-08-21 |
2011-01-05 |
Otsuka Pharmaceutical Co., Ltd. |
Lactic acid bacteria having mucosal immunopotentiation effect
|
|
GB0330009D0
(en)
*
|
2003-12-24 |
2004-01-28 |
Ferrosan As |
Probiotic tablet formulations
|
|
US20080286253A1
(en)
|
2004-02-09 |
2008-11-20 |
Transfert Plus Societe En Commandite |
Composition Comprising Polymeric Material And Uses Thereof
|
|
US20050260181A1
(en)
|
2004-03-05 |
2005-11-24 |
Immunopath Profile, Inc. |
Compositions and methods for tissue repair
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
GB0410785D0
(en)
|
2004-05-14 |
2004-06-16 |
Glycologic Ltd |
Improved prebiotic
|
|
WO2005115341A2
(en)
|
2004-05-27 |
2005-12-08 |
Advanced Bionutrition Corporation |
Microparticles for oral delivery
|
|
DE102004026706A1
(de)
|
2004-05-28 |
2005-12-15 |
Merck Patent Gmbh |
Orale Darreichungsform enthaltend probiotische Bakterien
|
|
US20060062773A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for maintaining and restoring normal gastrointestinal flora
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
ATE515198T1
(de)
|
2005-05-18 |
2011-07-15 |
Dsm Ip Assets Bv |
Zusammensetzung für die enterale verabreichung von mikroorganismen
|
|
ES2526094T3
(es)
|
2005-09-29 |
2015-01-05 |
Merck Patent Gmbh |
Procedimiento para estabilizar formas de administración farmacéuticas que contienen microorganismos
|
|
US7982066B2
(en)
|
2005-12-09 |
2011-07-19 |
Novalife, Inc. |
High protein supplement
|
|
PL1962873T3
(pl)
|
2005-12-14 |
2014-03-31 |
Oxthera Intellectual Property Ab |
Kompozycje farmaceutyczne zawierające bakterie zmniejszające ilość szczawianu
|
|
US20070184111A1
(en)
|
2006-02-03 |
2007-08-09 |
Pharmavite Llc |
Hybrid tablet
|
|
WO2008076975A1
(en)
|
2006-12-18 |
2008-06-26 |
Advanced Bionutrition Corporation |
A dry food product containing live probiotic
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
US20080171085A1
(en)
|
2007-01-11 |
2008-07-17 |
Natrol, Inc. |
Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
|
|
US8066986B2
(en)
*
|
2007-02-01 |
2011-11-29 |
Master Supplements, Inc. |
Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
|
|
EP2409691A1
(en)
|
2007-04-04 |
2012-01-25 |
Sigmoid Pharma Limited |
Pharmaceutical cyclosporin compositions
|
|
WO2009020595A2
(en)
*
|
2007-08-03 |
2009-02-12 |
Shaklee Corporation |
Nutritional supplement system
|
|
US20100239682A1
(en)
|
2007-09-17 |
2010-09-23 |
Antoine Andremont |
Colonic delivery of antimicrobial agents
|
|
US9078824B2
(en)
|
2007-09-24 |
2015-07-14 |
The Procter & Gamble Company |
Composition and method of stabilized sensitive ingredient
|
|
US20100226995A1
(en)
|
2007-11-12 |
2010-09-09 |
Debrouse Daniel R |
Microencapsulated bioactive agents for oral delivery and methods of use thereof
|
|
US20110223248A1
(en)
|
2007-12-12 |
2011-09-15 |
Ritter Pharmaceuticals, Inc. |
Methods and compositions for treating lactose intolerance
|
|
EP2244593B1
(en)
|
2008-01-24 |
2015-06-10 |
Nestec S.A. |
Capsule containing nutritional ingredients and method of delivery of a nutritional liquid from the capsule
|
|
CN102014926A
(zh)
|
2008-05-01 |
2011-04-13 |
宝洁公司 |
用于治疗炎性肠病的方法和试剂盒
|
|
WO2009149149A1
(en)
|
2008-06-04 |
2009-12-10 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
CN102123604A
(zh)
*
|
2008-06-24 |
2011-07-13 |
Wm.雷格利Jr.公司 |
益生菌口香糖的制造方法
|
|
WO2010028489A1
(en)
|
2008-09-15 |
2010-03-18 |
Labopharm Inc. |
Starch-based microparticles for the release of agents disposed therein
|
|
KR20110097829A
(ko)
*
|
2008-11-14 |
2011-08-31 |
포톨라 파마슈티컬스, 인코포레이티드 |
낮은 ｐＨ에서 불량한 수용해도를 갖는 이온화가능한 활성제의 제어 방출을 위한 고체 조성물, 및 그의 사용 방법
|
|
GB0900551D0
(en)
|
2009-01-14 |
2009-02-11 |
Horton Richard |
Ingestible compositions and processes of preparation
|
|
EP2381799B1
(en)
|
2009-01-27 |
2018-08-08 |
Probiotical S.p.a. |
Chocolate flavoured probiotic supplement
|
|
KR20110124780A
(ko)
|
2009-02-24 |
2011-11-17 |
리터 파마슈티컬즈 인코오포레이티드 |
프리바이오틱 제제 및 사용 방법
|
|
US8785160B2
(en)
|
2009-02-24 |
2014-07-22 |
Ritter Pharmaceuticals, Inc. |
Prebiotic formulations and methods of use
|
|
JP2012520325A
(ja)
|
2009-03-13 |
2012-09-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
プレバイオティックオリゴ糖
|
|
US20100330151A1
(en)
|
2009-06-25 |
2010-12-30 |
Mary Elaine Freeland |
Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate
|
|
US20120087902A1
(en)
*
|
2009-07-20 |
2012-04-12 |
Bracco S.P.A. |
Therapeutic Use Of Probiotics
|
|
CN102470152A
(zh)
|
2009-07-30 |
2012-05-23 |
丹尼斯科公司 |
用于治疗内毒素血症的乳酸菌和双歧杆菌
|
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
|
MX348611B
(es)
|
2009-12-31 |
2017-06-21 |
Milton Trachtman Ira |
Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana.
|
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
|
KR101143997B1
(ko)
|
2010-03-04 |
2012-05-09 |
한미사이언스 주식회사 |
유산균 제제 및 5-ｈｔ4 수용체 효능제를 함유하는 경구 투여용 복합 제제 및 이의 제조방법
|
|
US9301982B2
(en)
|
2010-04-14 |
2016-04-05 |
Ganeden Biotech, Inc. |
Probiotic confection and lipid compositions
|
|
EP2571894A1
(en)
|
2010-05-19 |
2013-03-27 |
North Carolina State University |
Compositions and methods for the delivery of therapeutic peptides
|
|
US20140154312A1
(en)
|
2010-09-17 |
2014-06-05 |
Monica Gulati |
Oral targetted drug delivery system
|
|
US8691275B2
(en)
*
|
2011-01-28 |
2014-04-08 |
Zx Pharma, Llc |
Controlled-release melatonin compositions and related methods
|
|
ES2561253T3
(es)
*
|
2011-03-17 |
2016-02-25 |
Probiotical S.P.A. |
Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
|
|
WO2012154738A1
(en)
|
2011-05-09 |
2012-11-15 |
The Cleveland Clinic Foundation |
Composition and method to improve intestinal health
|
|
ES2660775T3
(es)
|
2011-05-16 |
2018-03-26 |
Belano Medical Ag |
Nuevas bacterias del ácido láctico y composiciones que las contienen contra los resfriados bacterianos
|
|
CN202427429U
(zh)
*
|
2012-01-09 |
2012-09-12 |
北京大北农科技集团股份有限公司 |
一种多层微囊制备设备
|
|
US20130295227A1
(en)
|
2012-05-01 |
2013-11-07 |
Robbert H. ter Haar |
Composition Comprising a Sensitive Ingredient
|
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
|
US20140112985A1
(en)
|
2012-10-22 |
2014-04-24 |
Polonez Therapeutics Llc |
Method of prevention and treatment of clostridium difficile infection
|
|
EP2958575B1
(en)
*
|
2013-02-22 |
2019-04-03 |
The Regents of The University of California |
Composition comprising lactobaccilus johnsonii 456 and its use in treating or preventing diseases
|
|
EP2968187A4
(en)
*
|
2013-03-14 |
2016-08-17 |
Therabiome Llc |
TARGETED GASTROINTESTINAL RELEASE OF PROBIOTIC ORGANISMS AND / OR THERAPEUTICS
|